MedPath

LINK HEALTHCARE HONG KONG LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

PPB:7

Drug Approvals

CUFENCE CAPSULES 200MG

Approval Date
May 2, 2023
PPB

FOSCAVIR SOLUTION FOR INFUSION 6G/250ML

Approval Date
Feb 23, 2023
PPB

PENTHROX INHALATION LIQUID 99.9%

Approval Date
Oct 20, 2018
PPB

ALLMERCAP MERCAPTOPURINE ORAL SUSPENSION 20MG/ML

Approval Date
Nov 28, 2017
PPB

CARDIOXANE FOR INJ 500MG

Approval Date
Oct 30, 2006
PPB

IMMUKIN INJ 100MCG/0.5ML

Approval Date
Sep 5, 1998
PPB

NATACYN OPHTHALMIC SUSPENSION 5%

Approval Date
Jan 14, 1997
PPB

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.